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1. INTRODUCTION 
In 1902 Bayliss and Starling described the first 
hormone, secretin, when they characterized a 
pancreatic stimulant that was secreted into the 
circulation in response to duodenal acidification. 
In subsequent studies this and many other 
hormones were identified as small polypeptides 
with widespread distribution throughout the 
body. Many of  these polypeptides have been 
proposed as neurotransmitters in the peripheral 
and central nervous systems. However, the 
evidence for a neurotransmitter function for these 
peptides has been limited primarily to simple 
localization by immunologic means to nerve 
tissues. Many of  the peptides in question have not 
been purified from nerves and thus the 
relationship of  their immunoreactivities to 
chemical structures is unknown. 
The complexity of  the brain makes 
neuropeptide studies such as biosynthesis and 
release experiments, correlation of  localization to 
known cellular function on the basis of  
electrophysiologic studies, and determination of  
specific cellular receptors difficult to perform as 
well as to interpret. The retina, however, provides 
an ideal system for further exploration of  the 
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Fl6. 1. SLl-containing cell bodies and processes stained by indirect immunofluorescence in 10 lain frozen sections oF 
goldfish retina. The calibration marker in (c) represents 20/am in (a - e) and 80 um in (f). The inner plexiform layers (IPL) 
are marked by the vertical lines and the inner limiting membranes ( |LM) are marked by the horizonal lines. (a) Large 
unbranched process extending from a large round cell body (SAal). (b) Fine varicose fibers forming a plexus in the distal 
IPL originating from a small spherical perikaryon (SAa2). (c) SAM and SAa2 cells with their processes in a tangential 
section, illustrating the origin of  thick processes from the large cells and thin processes from the smaller cells. (d) Cell in the 
ganglion cell layer (SGb) associated with smooth processes. (e) Pyriform perikaryon with processes descending into the 
most proximal sublamina of the IPL (Sab). (f) Low-power view of tangential section of retina, illustrating the 
predominance of  fine varicose fibers amid numerous perikarya. The names of the cell bodies containing SLI were derived 
as follows: S = somatostatin-containing; A = amarine cell layer, G = ganglion cell layer; a and b refer to the location of the 
processes in the inner plexiform layer; and 1 and 2 refer to the subtypes. Hence, SAa2 refers to somatostatin-containing 
cells in the amacrine cell layer of the retina with processes in sublamina a, type 2. (From Yamada et al., 1980). 
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FIG. 2. Diagram of four types of SLI-containing cell 
bodies with their processes, Sublaminae a and b of the 
inner plexiform layer (IPL) are marked. (From Yamada 
et al., 1980). 
Nesbitt, 1981). It is an integral but discreet 
component of the brain which can be isolated 
without damage to its intrinsic neurons and can be 
maintained in organ culture for prolonged 
periods. Moreover, the anatomy, physiology, and 
pharmacology of the retina have been extensively 
characterized. Each of the major cell types have 
been studied by intracellular recording (Kaneko, 
1979). Because the retina responds to light, it can 
be activated by the same light stimuli in vitro that 
it responds to in vivo. Since discreet populations 
of retinal cells can be activated with different light 
or pharmacologic stimuli, the retina provides an 
unique opportunity in which to perform parallel 
electrophysiological and biochemical studies. 
For these reasons, a number of investigators 
initiated studies to localize neuroactive peptides in 
the retina. Schaeffer et al. (1977) first found 
thyrotropin releasing hormone-like immuno- 
reactivity (TRH-LI) by radioimmunoassay in 
extracts of rat retina and observed that levels of 
this peptide increased during exposure of animals 
to light. Since these initial observations, a number 
of peptides have been localized to the retina, 
primarily by immunohistochemical techniques, as 
reviewed by Stell et al. (1980) and Brecha (1983). 
Among the peptides that my collaborators and I 
have examined is somatostatin. 
The isolation of somatostatin was initially 
reported in 1973 by investigators in Guillemin's 
laboratory as an unexpected dividend in the search 
for the hypothalamic releasing factor responsible 
for regulation of pituitary growth hormone 
secretion (Brazeau et al., 1973). In their early 
attempts to isolate thyrotropin releasing factor 
and luteinizing hormone releasing factor, they 
observed a consistent inhibition of growth 
hormone secretion from dispersed rat pituitary 
cells in culture by fractions of their hypothalamic 
extracts, much as Krulich et al. (1968) had 
described several years earlier. Because of the 
reproducibility of their findings, Brazeau et al. set 
out to purify this somatotropin-release inhibiting 
factor (SRIF) from a chloroform-methanol-glacial 
acetic acid extract of 500,000 sheep hypothalami 
and isolate the cyclic tetradecapeptide that we 
know today as somatostatin. Following these 
initial studies, numerous additional pharma- 
cological actions of somatostatin were described 
in rapid succession, not only on pituitary hormone 
secretion, but on functions of such diverse organs 
as the pancreatic islets and the stomach. It was not 
until 1975, however, that Arimura et al. (1975) 
desribed the first radioimmunoassay for somato- 
statin and with it, the first hints as to the 
ubiquitous distribution of the peptide in its 
multiple molecular forms were provided. Today, 
somatostatin-like immunoreactivity (SLI) is 
known to be present in virtually every tissue in the 
body, and as aptly described by Reichlin (1983), 
"the names of the organisms shown to contain 
immunoreactive somatostatin read like the 
passenger's list of Noah's ark",  and include not 
only the familiar vertebrates, but also 
protochordates, plants, protozoa, and even 
prokaryotes. 
The primary evidence that somatostatin is a 
neurotransmitter is that somatostatin-like 
immunoreactivity (SLI) has been identified in 
axons and nerve cell bodies of primary sensory 
neurons (Hokflet et al., 1975), sympathetic 
neurons (Hokfelt et al., 1977), and intrinsic 
neurons of the intestines (Hokfelt et al., 1975; 
Costa et al., 1977), as well as in neurons of the 
central nervous system (Krisch, 1978). In addition, 
SLI has been localized to secretory granules within 
the median eminence (Pelletier et al., 1974) and 
terminal synaptosomes of neurons of the 
hypothalamus (Epelbaum et al., 1977; Styne et al., 
1977). SLI release from nerve tissues by 
depolarization has been shown to be calcium- 
dependent (Iverson et al., 1978) and electro- 
physiological studies have demonstrated that 
somatostatin in low concentrations affects the 
discharge rate of neurons in various regions of the 
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FIG. 3. A vertical section of  sublamina a of  the inner plexiform layer. The edge of  the original 100 gm tissue chopper 
section is at the left. Three labeled amacrine cell processes are marked with arrowheads. The calibration bar is 2 tam. 
Abbreviations: A, amacrine cell process; B, bipolar cell axon termina; G, ganglion cell dendrite; The letter symbols are 
used in succeeding figures. (From Marshak et al.,  1984). 
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FIG. 4. A vertical section through sublamina b of the inner plexiform layer. The labeled process increased in diameter near 
the center of the micrograph and is presynaptic to a presumed ganglion cell dendrite (G) at the site between the arrows. The 
postsynaptic process did not contain any presynaptic specializations in the 12 adjacent, serial sections. The thick arrowhead 
indicates a large, dense-cored vesicle. The calibration bar is 0.5/am. (From Marshak et al., 1984). 
FIG. 5. A vertical section through sublamina b of the 
inner plexiform layer. The site of synaptic input from the 
labeled amacrine cell process is between the arrows. The 
postsynaptic cell was identified as a bipolar cell by its 
characteristic indented shape, high synaptic vesicle 
density, high cytoplasmic electron density, and synaptic 
ribbon (arrowhead). The calibration bar is 1/am. (From 
Marshak et al., 1984). 
FIG. 6. A vertical section through sublamina a of the 
inner plexiform layer. The synaptic ribbon (arrowhead) 
of this bipolar cell axon terminal has been sectioned 
tangentially. This terminal is presynaptic to the labeled 
amacrine cell process below. The calibration bar is 
0.5/am. (From Marshak et al., 1984). 
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FIG. 7. A tangential section through sublamina a of the 
inner plexiform layer. A bipolar cell telodendron receives 
a synapse from a labeled amacrine cell process at the site 
between the arrows. This telodendron was traced to the 
terminal of a large, mixed, rod-cone bipolar cell in 
adjacent sections. The calibration bar is 1 lam. BT, 
bipolar cell telodendron. (From Marshak et al., 1984). 
F~c. 9. A vertical section through sublamina a of the inner 
plexiform layer. The unlabeled amacrine cell process 
contains a few small, electron-lucent vesicles which are 
not clustered near the site, between the arrowheads, 
where it receives a synaptic contact from the labeled 
amacrine cell process. The calibration bar is 0.5/am. As, 
amacrine cell soma. (From Marshak et al., 1984). 
F1¢5.8. A vertical section through sublamina b of the 
inner plexiform layer. The amacrine cell contains small, 
electron-lucent vesicles, which are clustered at the 
arrowhead, where it is presynaptic to an unlabeled 
process and near the site between the arrows, where it is 
presynaptic to the labeled amacrine cell process. The 
calibration bar is 0.5 ~m. (From Marshak et al., 1984). 
FIG. 10. A vertical section through the border between the 
inner nuclear and inner plexiform layers. The soma of this 
amacrine cell was identified by its position in the most 
proximal row of the inner nuclear layer. It receives a 
synaptic contact from the labeled amacrine cell process at 
the site between the arrows. The arrowhead indicates 
unlabeled, large, dense-cored vesicles in an adjacent 
process. The calibration bar is 0.5 jam. (From Marshak et 
al., 1984). 
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TABLE. 1. Identified Synapses o f  Amacrine Cells Containing 
SLI* 
Type to SLI cells Sublamina a Sublamina b 
Presynaptic 
Bipolar 2 (12%) 1 (11%) 
Amacrine 15 (88%) 8 (89%) 
Postsynaptic 
Bipolar 2 ( 5 % )  2 ( 8 % )  
Amacrine 23 (53%) 15 (58%) 
Ganglion 18 (42%) 9 (35%) 
*Table 1 summarizes 95 identified synapses made by labeled 
cells - -  31 from serial sections in the tangential plane and 64 
from serial sections in the vertical plane. In each column the 
number of contacts of each type observed is given followed in 
parentheses by the percentage of the total presynaptic or 
postsynaptic in that sublamina. (From Marshak et al., 1984). 
brain (Dodd and Kelly, 1978; Ioffe et al., 1978; 
Renand et al., 1975), dorsal horn of the spinal 
cord (Randic and Miletic, 1978), and myenteric 
plexus of the intestines (Guillemin, 1976). 
Furthermore, a system for rapid sequestration and 
degradation of somatostatin has been identified in 
brain capillaries (Pardridge et al., 1985). 
During the past several years my principal 
collaborators (David Marshak, Scott Basinger, 
and Mimi Takami) and I have concentrated on 
extending our initial description of SLI in discreet 
cells in the amacrine cell layer of the retina 
(Yamada et al., 1980) to ultrastructional 
characterization of the SLI-containing retinal cell 
(Marshak et al., 1986), examination of the 
pathways of SLI biosynthesis (Yamada and 
Basinger, 1982), and characterization (Marshak et 
al., 1984) and isolation of retinal SLI (Marshak et 
al., 1983; Takami et al., 1985). We hope that these 
studies will provide the groundwork upon which 
future physiological studies with somatostatin 
peptides of known structure can be undertaken by 
ourselves as well as by others. In addition, we 
hope that our observations have shed light on the 
nature of somatostatin molecular biology by 
providing an understanding of the pathways of 
post-translational processing of the somatostatin 
precursor. 
2. LOCALIZATION 
2.1. Light Microscopy 
Although SLI has been found in retinas from a 
variety of species (Stell et al., 1980; Brecha, 1983), 
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this review will focus on the localization of SLI in 
the goldfish since extensive characterization of 
SLI-containing neurons in the retina at both the 
light and electronmicroscopic level has only been 
achieved in these species. 
For light microscopic studies, the enucleated 
eyes of light-adapted goldfish were sectioned 
longitudinally through the optic disc and those of 
dark-adapted fish were sectioned equatorially. 
The retinas were dissected free and fixed in 4°70 
(wt/vol.) paraformaldehyde in a phosphate- 
buffered saline (PBS) solution (0.05M sodium 
phosphate, 0.4M NaCI, pH 7.2) for 16 hr. After 
incubation in 30°70 sucrose in PBS for 24 hr, the 
tissues were frozen, then 10/am sections were 
obtained and mounted on gelatin-coated slides. 
The sucrose was removed by rinsing in PBS and 
the specimens were incubated for 2 hr at 37 ° with 
somatostatin antisera and then for 30 min in 
fluorescein isothiocyanate conjugated goat anti- 
rabbit gamma globulin. Appropriate controls 
were obtained with non-immune rabbit serum or 
somatostatin antiserum absorbed with 60 /aM 
somatostatin. After rinsing in PBS, the slides were 
mounted in glycerol/PBS (3:1, vol.:vol.) and 
examined by epi-illumination. 
As depicted in Fig. 1, 3 distinct SLI-containing 
cell types were identified in the amacrine cell layer 
of the goldfish retina and a fourth was identified 
in the ganglion cell layer. In addition, a prominent 
plexus of fine varicose fibers interspersed with 
larger unbranched processes 2 - 3 / a m  in diameter 
was identified with the somatostatin antiserum in 
the distal half of the outer sublamina (sublamina 
a) of the inner plexiform layer (Figs la, b, and f). 
Two types of processes descended to the inner 
sublamina of the inner plexiform layer (sublamina 
b) where they formed a second plexus. One of 
these types was relatively thick (1 /am in diameter 
at the base) and arborized as it coursed through 
the inner plexiform layer; the other was thin and 
did not arborize (Fig. l e). 
Approximately 5°70 of the proximal row of ceils 
in the inner nuclear layer contained SLI and there 
were 3 primary types. One type (SAal) had large 
round perikarya with thick smooth processes that 
extended laterally in sublamina a of the inner 
plexiform layer (Figs la and c). The fine varicose 
processes in this sublamina could be traced to 
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TABLE. 2. Concentrations o f  Somatostatin-like Immunoreactivity in Extracts o f  
Retinas f rom a Variety o f  Vertebrate Species 
SLI (pmol) 
Species Per gram Per retina Per gram Per retina 
Goldfish 13.6 4.0 
Carp 1.6 0.5 
Frog 9.8 0.5 
Chicken 25.3 3.5 62.2 (E) 
Rat 7.5 0.20 31.7 (E) 
Rabbit 4.3 0.16 4.3 (E) 
Hog 9.8 1.9 







Data obtained in our laboratory are listed on the left. The hog and rabbit 
retinas were extracted in acid/acetone; the rest were extracted in 3 °7o acetic acid. 
Results from other laboratories are listed on the right. BU = Buckerfield et al., 
1981; E = Eskay et al., 1980; L = Lake and Patel, 1980; R = Rorstad et al., 1979, 
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Fic. 11. Sephadex G50 sf chromatography of retinal 
extracts from rat (a), hog (b), and chicken (c). The elution 
volume (V~) had been expressed as K~, (equal to V~- V,,/ 
V , -  V,,) to normalize for differences in column size. The 
columns were calibrated by noting the elution volume of 
NaCI (V,), bovine serum albumin (V,,), somatostatin-14 
(SI4) and somatostatin-28 ($28). (From Marshak and 
Yamada, 1984). 
Flc;. 12. Sephadex G50 chromatography of bovine retinal 
extracts. Extracts were chromatographed before and after 
1 hr of incubation in 8 M urea. Both samples were applied 
to the same column (1 × 120 cm) of Sephadex G50 sf 
equilibrated in 0.1 M ammonium acetate, pH 5.0. Each 
2 ml fraction that was eluted was assayed for SLI. The 
column was calibrated as noted in Fig. I1. (From 
Marshak and Yamada, 1984). 
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FIG. 13. Incorporation of (35S)cysteine by frog retinas into 
material adsorbable with somatostat in-affini ty column. 
Three sets of  10 retinas were pulse-labeled in medium 
containing (~SS)cysteine (47.6/aCi/ml) One set of  retinas 
was boiled prior to incubation; another set was 
preincubated for 15 min as well as pulse-labeled in 
medium containing 0.2 mM cycloheximide, and the third 
set was incubated in standard fashion. At 0, 0.5, 1, 2, and 
4 hr, two retinas were removed from pulse medium and 
extracted with 3070 acetic acid. The neutralized extracts 
were applied to somatostat in-affini ty column and eluted 
with 10070 acetic acid. The affinity eluates were counted in 
a liquid scintillation spectrometer. (From Yamada  and 
Basinger, 1982). 
originate from a second cell type (SAa2) that had 
smaller spherical perikarya (Fig. lb). A third cell 
type (SAb) had large pyriform perikarya with both 
thick and thin processes that descended to 
sublamina b of the inner plexiform layer (Fig. le). 
The possibility that this cell type also gave rise to 
the thin varicose processes in sublamina a could 
not be excluded. One cell type (SGb) with 
somewhat flattened perikarya in the outermost 
layer of the ganglion cell layer (Fig. ld) was also 
identified as containing SLI. It gave rise to fine 
smooth processes that extended along the most 
proximal portion of sublamina b of the inner 
plexiform layer. The various SLI-containing cells 
of the goldfish retina and their processes are 
depicted in schematic form in Fig. 2. 
2.2. Electronmieroseopy 
To characterize the ultrastructure of the 
processes of SLI containing neurons in the retina 
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FIG. 14. Disappearance of  affinity-adsorbable 
radioactivity from pulse-labeled retinas following chase- 
incubation in radioactivity-free medium. A set of  10 
retinas was pulse-labeled with (35S)cysteine for 15 min and 
transferred to nonradioactive chase medium. At 15, 45, 
105, 225, and 345 min of  chase incubation (0.5, 1, 2, 4, 
and 6 hr of  total incubation), two retinas and 1 ml of  
medium were removed, extracted, subjected to affinity 
chromatography,  and assayed for radioactivity. The 
affinity-adsorbable radioactivity of  each milliliter of  
medium was multiplied by the total volume of  medium 
present in the incubation mixture at the time it was 
sampled to obtain a value for total affinity-adsorbable 
radioactivity in the medium. (From Yamada and 
Basinger, 1982). 
and examine their synaptic connections, we 
extended our immunohistochemical studies to the 
electronmicroscopic level. For these studies 
goldfish retinas were fixed in 4°70 paraformalde- 
hyde and 0.05070 glutaraldehyde, embedded in I o70 
low-gelling temperature agarose and 100 /am 
sections were cut and labeled using the peroxidase- 
antiperoxidase method. Serial ultrathin (10 /am) 
sections were collected on copper grids and then 
coated with carbon and photographed. 
Since the sections examined for electron- 
microscopy were obtained at random, largely 
from the inner plexiform layer (Fig. 3), the 
majority of labeled fibers represented the beaded 
dendrites of the SAa2 and SAb type SLI cells. 
Both the thin portion and the bulbous swellings 
associated with these processes are depicted in Fig. 4. 
The synapses, as demonstrated in this figure, were 
identified as the parallel, straight, widely spaced, 
and electron dense portions of the opposing 
membranes on the pre- and post-synaptic cells. 
I 18 T. YAMADA 
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FI(L 15. Chromatographic  elution of affinity-adsorbable 
radioactivity in retinal extracts and in chase medium. 
After a 30 min pulse-labeling in (~SS)cysteine-containing 
medium, and a 30 min incubation in 30 ml of chase 
medium, a set of  six retinas was incubated in 2 ml of  fresh 
chase medium for an additional 30 rain. The retinas and 
medium were then extracted and affinity-adsorbed, and 
the affinity eluate was applied to a Sephadex G50 
(superfine) column (1 x 120 cm) and eluted with 0.1 M 
ammon ium acetate, pH 5.0. Aliquots of  eluted 2.2 ml 
fractions were assayed for radioactivity. The columns 
were calibrated by elution of bovine serum albumin (V J ,  
NaCI (VJ, somatostat in 14 (S14), and somatostat in 28 
($28). (From Yamada  and Basinger, 1982). 
Some labeled processes also contained large dense- 
cored vesicles but these were not localized in the 
area adjacent to the pre-synaptic specialization. 
Other smaller vesicles with electron-luscent centers 
were also distributed throughout the processes but 
appeared to cluster at sites of  synaptic 
specialization. Synaptic junctions between 
dendrites o f  various SLI containing cells and those 
o f  the other cells with processes in the inner 
plexiform layer are depicted in Figs 5 -  10. After 
examining a large number o f  sections, we 
observed that SLI containing retinal processes 
both received most  o f  their synaptic inputs from 
and extended most  of  their outgoing synapses to 
other amacrine cells (Table 1). However,  a 
substantial number of  contacts were also made 
with ganglion cells and, to a lesser extent, bipolar 
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FIG. 16. Change in chromatographic elution pattern of 
affinity-adsorbable radioactivity obtained from retinas 
pulse-labeled with (35S)cysteine for 3 min and then 
incubated in chase medium for 3, 9 or 27 min,  or pulse- 
labeled for 15 min and incubated in chase medium for 45, 
105, or 345 min. The affinity eluates were 
chromatographed on a Sephadex G50 (superfine) column 
as described in Fig. 15 and fractions were assayed for 
radioactivity. (From ¥ a m a d a  and Basinger, 1982). 
cells. Of  particular note was that the pattern o f  
synapses did not differ between processes in 
sublamina a and b. 
3. C H A R A C T E R I Z A T I O N  OF M O L E C U L A R  
FORMS 
3.1. Contents of SL! 
For initial biochemical characterization, we 
examined the contents and molecular forms of  
SLI in the retinas of  a variety of  species. Whole  
retinas were obtained from freshly killed animals 
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FiG 17. Elution of biosynthetic (35S)SLI peak 1V (see Fig. 
15) and synthetic somatostatin-14 on high pressure liquid 
chromatography using a uBondapak C18 column (0.39 x 
30 cm). Fractions (1 ml) were eluted isocratically with 
29% acetonitrile in 0.1070 trifluoroacetic acid at a flow 







and extracted in 3°70 acetic acid. In a few 
instances, extractions were also performed using 
acetone (70070) in 3070 acetic acid. The recovery of 
somatostatin-14 (S14) or somatostatin-28 
exogeneously added to the retinas before the 
extraction process averaged 90-100070. After 
extraction, aliquots were applied to gel 
chromatography on Sephadex G50 superfine 
columns equilibrated and eluted with either 0. I M 
ammonium acetate pH 5.0 or 1070 acetic acid. 
Each eluted fraction and the original extracts were 
analyzed for SLI by radioimmunoassay using an 
antiserum (Ab 1001) that is specific for the ring 
portion of S14 and cross-reacts 50°70 with $28. 
The concentrations of SLI in various vertebrate 
retinas is depicted on Table 2. The data obtained 
in our laboratory generally were comparable to 
those reported by others. Of particular note was 
the high concentration of SLI present in bovine 
retina, an observation that proved to be useful 
when the purification of retinal SLI was 
undertaken (vide infra). It was of great interest 
that species as closely related as goldfish and carp 
had such widely varying concentrations of retinal 
SLI, but similar differences have been reported 
between Rana catesbiana and Rana pipiens (Eskay 
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FIG. 18. Displacement of biosynthetic (3~S)SLI peak IV 
(O-see Fig. 15) and t~I-Tyrt-somatostatin ( e )  from anti- 
somatostatin antibody in the presence of increasing 
concentrations of unlabeled somatostatin- 14. 
Displacement is expressed as a ratio of bound counts at 
any given unlabeled somatostatin concentration (B) to 
bound counts in the absence of added somatostatin (Bo). 
(From Yamada and Basinger, 1982). 
3.2. Molecular Forms 
As in many other tissues, SLI was present in 2 
major molecular forms, one that corresponded to 
S14 and the other that corresponded to $28 
(Fig. 11). In the case of bovine retina, another 
molecular form eluted as a larger molecule than 
$28 but gel filtration of the extracts under 
dissociative conditions revealed this to be a 
artifact caused by non-covalent association of S14 
with an unidentified macromolecule (Fig. 12). The 
species differences in distribution of SLI into the 
two major molecular forms were remarkable. 
Whereas most of the species studied had both $28 
and S14 forms, the rat had only the latter, while 
virtually all of the bovine retinal SLI was the 
former. These differences may reflect differences 
in post-translational processing of the 
somatostatin precursor in the retinas of the 2 
species. 
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FIG. 19. Purification of bovine retinal somatostatin-like immunoreactivity (SLI) by high-pressure chromatography. After 
extraction with 3070 acetic acid and purification by affinity chromatography, bovine retinal SL1 was applied sequentially to 
high-pressure liquid chromatography on reverse-phase C-18 (A) and phenyl columns (B-D) .  The columns were 
equilibrated in 0.107o trifluoroacetic acid then eluted with a stepwise gradient of 50070 acetonitrile in 0.1 °70 trifluoroacetic 
acid (buffer B) as indicated in each figure. A280 (A) or A220 (B - D) was monitored with a variable wavelength detector, 
and SLI in each fraction was quantified by radioimmunoassay. The fractions pooled for further purification ( A -  C) or 
amino acid sequencing (D) are indicated by the black bars. The elution position of synthetic somatostatin octacosapeptide 
($28) is indicated in D. (From Marshak et al., 1983). 
RETINAL SOMATOSTATIN 
TABLE. 3. Recovery of  Bovine Retinal SLI at each Step of  Purification 
Recovery (%) 
SLI Purification 
Step (nmol) Step Cumulative (X) 
Extract 18.6 - 100.0 1 
Affinity 19.3/11.8" ,~, 100.0 ~100.0 150 
HPLC ( C -  18) 9.0 76.0 76.0 16,500 
HPLC (Phenyl #)  3.8 42.2 42.2 32.2 46,000 
HPLC (Phenyl #2) 2.7 71.1 22.8 82,000 
HPLC (Phenyl #3) 1.7 62.9 14.4 103,000 
*Only 11.8 nmol of the total SLI was used for further purification; the rest was stored for 
future analysis. (From Marshak et al., 1983). 
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TABLE 4. Amino Acid Sequences o f  Purified Somatostatin 
Somatostatin 28 








1 2 3 4 5 6 7 8 9 10 II 12 13 14 
Set- Ala- Asn- Ser- Asn- Pro- Ala- Met- Ala- Pro- Arg- Glu- Arg- Lys 
Asp-Asn-Thr- Val- Thr- Ser- Lys- Pro 
15 16 17 18 19 20 21 22 23 24 25 26 27 28 
Ala- Gly- Cys- Lys-Asn-Phe-Phe-Trp- Lys- Thr- Phe- Thr- Ser- Cys 
_ _ ( C y s ) _  (Phe, Thr, Ser, Cys) 
Leu A s n _ _  Met Tyr Ser- Arg A l a _  
From Marshek et al., 1983. 
TABLE 5. Amino Acid Composition of  Bovine Retinal 
Somatostatin 
Amino acid Experimental Expected 
His 0.1 (0) 0 
Lys 3.0 (3) 3 
Trp* 0.0 (0) 1 
Arg ! .6 (2) 2 
Asx 4.3 (4) 3 
Thr 2.1 (2) 2 
Ser 3.1 (3) 3 
Glx 2.2 (2) 1 
Pro 3.0 (3) 2 
Gly 2.2 (2) 1 
Ala 3.9 (4) 4 
l/2Cys* 0.9 (1) 2 
Val 0.0 (0) 0 
Met 0.5 (1) 1 
lle 0.4 (0) 0 
Leu 0.4 (0) 0 
Tyr 0.2 (0) 0 
Phe 2.8 (3) 3 
*Under these hydrolysis conditions the recoveries of Cys and 
Trp are low. From Marshak et al., 1983. 
4.  B I O S Y N T H E S I S  O F  S L I  
4.1.  Label Uptake and Release 
In  o r d e r  to  c o n f i r m  tha t  t he  S L I  p re sen t  in t he  
r e t ina  r e p r e s e n t e d  the  p r o d u c t s  o f  loca l  pep t i de  
synthesis ,  a n d  to  ga in  ins igh t  in to  the  pos t -  
t r a n s l a t i o n a l  p roce s s ing  o f  s o m a t o s t a t i n  
p r ecu r so r s ,  we u n d e r t o o k  b io syn the t i c  s tudies .  
F o r  these  e x p e r i m e n t s  we used  the  f rog  re t ina  
because  o f  its u se fu lness  as a m o d e l  fo r  
e l e c t r o p h y s i o l o g i c a l  s tudies .  T h e  s t r a t egy  
e m p l o y e d  fo r  these  s tudies  was f irs t  to  i n c o r p o r a t e  
r a d i o a c t i v e  t r ace r  a m i n o  ac ids  in to  newly  
syn thes ized  S L I ,  a n d  t h e n  to  i m m u n o i m m o b i l i z e  
the  syn the t ic  p r o d u c t  f o r  q u a n t i t a t i v e  and  
q u a l i t a t i v e  s tudies .  
Re t i na s  were  s t r ipped  f ree  o f  p i g m e n t e d  
e p i t h e l i u m  a n d  r e m o v e d  in the  d a r k  f r o m  g r o u p s  
o f  d a r k - a d a p t e d  f rogs  ( R a n a  p ip iens ) .  T h e  re t inas  
were  t h e n  i n c u b a t e d  in K r e b s - R i n g e r  b u f f e r  
c o n t a i n i n g  8 / ag /ml  pen ic i l l in ,  12 / ag /ml  
122 T. YAMADA 
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FIG. 20. Yields of phenylthiohydantoin derivatives of amino acids derived from bovine retinal somatostatin by automatic 
Edman degradation. Approximately 3.0 nmol peptide (as estimated by amino acid analysis) were applied, but yield of the 
amino-terminal serine was only 380 pmol (12.7°70). Yields were calculated by comparison with standard after normalization 
for recovery, with diethylphthalate as an internal marker. Unmeasurable yields prevented amino acid sequencing beyond 
threonine in the 24th cycle. The absence of a clearly identifiable derivative in the 17th cycle is consistent with the presence 
of half-cysteine, which is not detected unless the native disulfide bond is chemically modified. (From Marshak et al., 1983). 
streptomycin, 200 kallikrein inhibitory units/ml 
Trasylol (FBA Pharmaceuticals, New York), and 
47.6 /aCi/m135S-cysteine (564 Ci/mmol,  New 
England Nuclear, Boston, Massachusetts). 
Following a 3 or 15 minute incubation in pulse 
medium, the retinas were transferred, after 
thorough washing, to chase incubation medium 
containing unlabeled L-cysteine (0.16 mM) and 
casamino acids (10 /ag/ml). At various time 
intervals 2 retinas and 1 ml of culture medium 
were removed, extracted in 3% acetic acid and 
neutralized. The samples were then applied to an 
affinity column made with anti-somatostatin 
antibody (7812) linked to Affi-Gel 10. The bound 
radioactivity was eluted with 10% acetic acid and 
counted in a liquid scintillation spectrometer. The 
affinity eluates were then chromatographed on a 
Sephadex G50 superfine column (1 x 120 cm) 
and eluted with 0.1 M ammonium acetate buffer, 
pH 5.0. 
As depicted on Fig. 13 affinity absorbable 
radioactivity (presumably newly synthesized SLI) 
gradually increased over the 4 hr duration of the 
study and this increase could be inhibited by 
nearly 75% with cycloheximide, indicating that it 
involved a conventional ribosomal process. 
During the first hour, roughly 28/aCi of 35S-cysteine 
was incorporated into SLI. Based on the specific 
activity of the label and assuming that at least one 
molecule of label was incorporated into each 
molecule of SLI, we calculated the basal rate of 
SLI synthesis to approximate 25 fmol/ret ina/hr.  
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FIG. 21. Elution profi le on reverse-phase phenyl high- 
pressure liquid chromatography of  SLI purified from 
bovine brain. Purification was achieved according to the 
protocol described in Fig. 19. The gradient profile is 
indicated. The elution positions of synthetic somatostatin 
tetradecapeptide (S14) and $28 are indicated at the top of 







Since the total SLI content in frog retinas is 
roughly 500 fmol/retina, the turnover rate of 
retinal SLI in the basal state appears quite low. 
When pulse-chase studies were performed, 
affinity adsorbable radioactivity in the retinas 
gradually decreased with time of incubation in 
chase medium (Fig. 14). A complementary 
increase in radioactivity was observed in the 
culture medium. Roughly 85% of total affinity- 
adsorbable radioactivity was recovered when the 
specific radioactivity of the retinas and medium 
were summated. This indicates that the turnover 
of SLI in unstimulated retinas can be accounted 
for largely by the basal release of the peptide. 
Radioactivity from the retinal extracts eluted from 
Sephadex GS0 in 4 distinct peaks: one in the void 
volume (peak I, Ka~ = 0.00), another which co- 
eluted with synthetic somatostatin 14 (peak IV, 
Ka~ = 0.84) and two intermediate in location 
(peaks II, Kav = 0.12; and III, Kav= 0.32) (Fig. 15). 
In contrast, only the peak corresponding to S14 
was secreted into the culture medium. This 
observation is particularly important since it 
indicates that the radioactivity appearing in the 
medium did not derive from leakage of 
intracellular contents but from selective release of 
peptide. The apparently selective release of S14 
despite the synthesis of other forms of SLI is 
curious but has been observed in other 
somatostatin biosynthetic systems (Chiba et al., 
1987). 
4.2. Post-Translational Processing of SLI 
When the chromatographic elution profile of 
SLI was examined over the time course of a pulse- 
chase experiment the distribution of radioactivity 
gradually shifted over time from peaks I and II to 
peaks III and IV (Fig. 16). However, no evidence 
of a shift of counts from peak III (corresponding 
to $28) to peak IV (corresponding to S14) was 
observed. Over 90% of radioactivity in pools of 
each of the peaks could be immunoprecipitated by 
incubation with anti-somatostatin antibody and 
goat anti-rabbit gamma globulin. Furthermore, 
the biochemical identity of peak IV was further 
confirmed by showing its co-elution with S14 on 
high pressure liquid chromatography (HPLC) 
(Fig. 17) and its parallel displacement with the 
standard curve by S14 in radioimmunoassay 
(Fig. 18). These findings suggest that the small 
molecular form of SLI synthesized in the retina is 
indistinguishable from S14 and, furthermore, that 
it does not derive from further post-translational 
modification of $28. The shift in radioactivity 
from the 2 larger peaks (I and II) to the two 
smaller peaks (III and IV) suggests the presence of 
2 precursor forms. We cannot confirm whether 
the smaller precursor form (peak II) represents a 
processing product derived from peak I or an 
independently synthesized precursor. The absence 
of these larger molecular forms of SLI on gel 
filtration of standard-tissue extracts may result 
from their relatively rapid conversion to smaller 
molecular forms which, in turn, accumulate in 
substantial quantities because of their slow 
turnover. 
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FIG. 22. Purification of frog brain SLI by HPLC. After extraction with 3% acetic acid and purihcatlon 0y attmlty 
chromatography, frog brain SL! was subjected to HPLC on reverse-phase C-18 Z-Module (A - C) and Vydac (D) columns. 
The columns were equilibrated in 0.1% TFA and then eluted with a stepwise gradient of 5007"0 acetonitrile in 0.1% TFA 
(buffer B) as indicated in each panel. A220 was monitored, and the SLI in each fraction was quantified by 
radioimmunoassay. The fractions pooled for further purification (A - C) or amino acid sequencing (D) are indicated by the 
black bars. The elution position of synthetic S14 as indicated in D. (From Takami et al., 1985). 
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5. S T R U C T U R E  OF R E T I N A L  
S O M A T O S T A T I N  
5.1. Bovine Retina 
In order to provide b iochemical  conf irmat ion  o f  
the i m m u n o c h e m i c a l  studies in the retina, we 
undertook  the purif ication o f  retinal SLI.  
Determinat ion  o f  the correct amino  acid 
sequences for retinal SLI is also an essential 
prerequisite for interpretation o f  physiological  
studies.  In examining a variety o f  vertebrate 
retinas for SLI as noted above,  we observed large 
differences in SLI concentrat ion even a m o n g  
c losely  related species.  However ,  on a unit basis,  it 
was clear that the bovine  retina would  be the mos t  
practical source for purif ication o f  retinal SLI.  In 
contrast  to the retinas o f  frogs,  goldfish,  chickens 
and hogs which contain roughly equal amounts  o f  
SLI comparable  to S14 and $28, nearly all o f  the 
bovine retinal SLI co-eluted with $28 on Sephadex 
G50 co lumn chromatography.  For purif ication 
3000 freshly obtained bovine retinas were extracted 
in boil ing 3% acetic acid and the neutralized 
extracts were applied to chromatography  on 
affinity beads made  by l inking ant i -somatostat in  
ant ibody to Aff i -Gel  10 beads. The beads were 
washed sequential ly with distilled water, 0.1 M 
a m m o n i u m  acetate pH 5.0, and 4 M guanidine 
HCI,  then the immobi l i zed  SLI was eluted with 
2% trif luoroacetic  acid. The affinity eluates were 
further purified by H P L C  in a /~ -Bondapak  C l 8  
co lumn and three sequent ia l /~ -Bondapak phenyl  
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FIG. 23. Purification of frog retinal SLI by sequential 
HPLC on reverse phase C-18 Z-Module columns (A and B) 
and a C-18 Vydac column (C). The columns were 
equilibrated and calibrated as in Fig. 22. (From Takami e t  




0.1070 trifluoroacetic acid as buffer (Fig. 19). On 
the last phenyl HPLC column, a single sharp A220 
peak was eluted and corresponded to the elution 
peak of SLI. This peak co-eluted with a synthetic 
$28 standard chromatographed on the same 
column. The final 1.7 nmol of purified SLI 
represented a cumulative recovery of 14.4070 and a 
SOMATOSTATIN 125 
purification factor of 103,000-fold (Table 3). On 
automated Edman degradation amino acid 
sequencing of the purified retinal SLI (Fig. 20), 
the structure of the first 24 amino acids was 
determined to be identical to that of $28 (Table 4) 
purified from hog intestine (Pradayrol et al., 
1980) and from ovine (Esch et al., 1980) and 
porcine hypothalamus (Schally et al., 1980). The 
identity of the final 4 amino acids was confirmed 
by studies of antibody specificity and amino acid 
analysis (Table 5). A simultaneous partial 
purification of bovine brain SLI revealed HPLC 
peaks corresponding to both $28 and S14 
(Fig. 2 I). 
5.2. Frog Brain and Retina 
The findings obtained with bovine retina 
conferred physiological relevance to functional 
studies in the mammalian retina employing S14 
and $28, however, species differences in structure 
might limit interpretation of studies performed on 
retinas from submammalian species. The 
quantities of SLI extracted from submammalian 
retinas may be insufficient for any practical 
attempt at purification for the purpose of 
sequence analysis, however, our studies showing 
identical chromatographic properties on HPLC of 
purified SLI from retina and at least one 
molecular form of the peptide from brain 
indicated a possible solution to this problem. 
Detailed chemical characterization could be 
performed on minute quantities of purified retinal 
peptides and compared to their counterparts from 
brain which may be available in quantities 
sufficient for amino acid sequencing. With this 
logic in mind, we undertook the co-purification of 
frog brain and retinal SLI. We extracted the 
brains and retinas from 800 freshly killed frogs 
(Rana pipiens) in boiling 307o acetic acid and 
applied the extracts sequentially to affinity 
chromatography on Affi-Gel 10-antisomatostatin 
beads, multiple /a-Bondapak C-18 Z-module 
HPLC columns, and a final VYDAC C-18 HPLC 
column (Figs 22 and 23). Through these steps we 
were able to obtain 360 pmol of brain SLI purified 
l l0,000-fold and 10 pmol of retinal SLI purified 
93,000-fold (Table 6). 
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TABLE 6. Recovery of  Frog Brain and Retinal SLI at each Step of  Purification 
SLI Recovery (%) Purification 
Step (nmol) Step Cumulative (X) 
Brain 
Extract 9.60 - 100 1 
Affinity 6.60/3.30* 68.8 68.8 100 
HPLC (Z-Module #1) 3.23 97.9 67.3 11,000 
HPLC (Z-Module #2) 1.34 41.5 27.9 25,000 
HPLC (Z-Module #3) 0.78 58.2 16.2 60,000 
HPLC (Vydac) 0.36 46.2 7.5 110,000 
Retina 
Extract 0.44 - 100 I 
Affinity 0.10 22.7 22.7 200 
HPLC (Z-Module #1) 0.06 60.0 13.6 9,000 
HPLC (Z-Module #2) 0.02 33.3 4.5 66,000 
HPLC (Vydac) 0.01 50.0 2.3 93,000 
*Only 3.30 of the 6.60 nmol were further purified. From Takami et al., 1985. 
The finally purif ied SLI f rom bra in  and ret ina 
co-eluted in the same fract ion which was also 
identical to the e lut ion fract ion of s tandard  
synthetic S14. A m i n o  acid sequencing of frog 
bra in  SLI revealed it to be identical  in structure to 
S14 (Table 7) but  different  f rom some other 
somatostatins isolated from submammal ian  species 
(Table 5). Because of  the identical  chromato-  
graphic characteristics of the co-purif ied retinal 
and bra in  SLI, we inferred that  the structures 
were likely to be identical,  hence funct ional  
studies performed with S14 on amph ib i an  ret ina 
may be interpreted in a physiologically relevant 
light. 
6. C O N C L U S I O N  
Somatos ta t in  is but  one example of  the m a n y  
polypeptides that  have been proposed as 
neurot ransmi t te rs  in the central  and  peripheral  
nervous systems. Our  experiments to characterize 
the ana tomy  and  biochemistry  of  somatos ta t in  in 
the ret ina hopeful ly  have provided the 
g roundwork  for future  studies to determine the 
physiological func t ion  of  retinal  somatosta t in .  
Such studies may  help to elucidate the role of  
peptide neuro t ransmi t te rs  in normal  and 
abno rma l  funct ions  of  the bra in .  Conversely,  the 
bra in  and,  more specifically, the ret ina has 
provided a convenient  and useful model  for 
examining the biochemistry and  molecular  biology 
of  bioactive peptides such as somatos ta t in .  
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